WASHINGTON, March 12 -- Law firms assisted companies in the following recently announced transactions - March 12, 2026: * * * Arnold & Porter advised Corstasis Therapeutics in its agreement to be acquired by Esperion Therapeutics. The transaction includes an upfront cash payment of $75 million and potential milestone payments totaling up to $180 million, along with royalties tied to future product sales. The acquisition is expected to close in the second quarter of 2026 subject to customary closing conditions and regulatory approvals. Ballar more ST